{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:14:13Z","timestamp":1787498053057,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13555-025-01414-1","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T07:19:14Z","timestamp":1745651954000},"page":"1487-1505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD"],"prefix":"10.1007","volume":"15","author":[{"given":"Pedro","family":"Mendes-Bastos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Lazaridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Aggelakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Katsantonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Aronis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicidade","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Papakonstantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera S. G.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6695-5848","authenticated-orcid":false,"given":"Aikaterini","family":"Kollia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaggelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"2","key":"1414_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2017.04.019","volume":"77","author":"L Eckert","year":"2017","unstructured":"Eckert L, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM. Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey. J Am Acad Dermatol. 2017;77(2):274-279.e3. https:\/\/doi.org\/10.1016\/j.jaad.2017.04.019.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1414_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.anai.2018.07.040","volume":"121","author":"JI Silverberg","year":"2018","unstructured":"Silverberg JI, Chiesa Fuxench ZC, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults. Ann Allergy Asthma Immunol. 2018;121(6):729-734.e4. https:\/\/doi.org\/10.1016\/j.anai.2018.07.040.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"1414_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"S Barbarot","year":"2018","unstructured":"Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, Margolis DJ, de Bruin-Weller M, Eckert L. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284\u201393. https:\/\/doi.org\/10.1111\/all.13401.","journal-title":"Allergy"},{"issue":"Suppl 7","key":"1414_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.18168","volume":"36","author":"M Augustin","year":"2022","unstructured":"Augustin M, Misery L, von Kobyletzki L, Armario-Hita JC, Mealing S, Redding M. Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe. J Eur Acad Dermatol Venereol. 2022;36(Suppl 7):3\u201316. https:\/\/doi.org\/10.1111\/jdv.18168.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1414_CR5","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.sder.2012.07.006","volume":"31","author":"CN Ellis","year":"2012","unstructured":"Ellis CN, Mancini AJ, Paller AS, Simpson EL, Eichenfield LF. Understanding and managing atopic dermatitis in adult patients. Semin Cutan Med Surg. 2012;31(3):S18\u201322.","journal-title":"Semin Cutan Med Surg"},{"issue":"6","key":"1414_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamadermatol.2013.10271","volume":"150","author":"JS Margolis","year":"2014","unstructured":"Margolis JS, Abuabara K, BilkerW HO, Margolis DJ. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol. 2014;150(6):593\u2013600.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1414_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jaci.2015.03.028","volume":"136","author":"K Abuabara","year":"2015","unstructured":"Abuabara K, et\u00a0al. Atopic dermatitis disease control and age: a cohort study. J Allergy Clin Immunol. 2015;136(1):190\u20132.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1414_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/jdv.18345","volume":"36","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, Bieber T, Brough HA, Calzavara Pinton P, Christen-Z\u00e4ch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, G\u00e1sp\u00e1r K, Gerbens L, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szalai ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. European guideline (EuroGuiDerm) on atopic eczema: part I\u2014Systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409\u201331. https:\/\/doi.org\/10.1111\/jdv.18345.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"1414_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1001\/jamadermatol.2016.1978","volume":"152","author":"AM Drucker","year":"2016","unstructured":"Drucker AM, Wang AR, Qureshi AA. Research gaps in quality of life and economic burden of atopic dermatitis: the National Eczema Association burden of disease audit. JAMA Dermatol. 2016;152(8):873\u20134.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"1414_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jaad.2016.05.028","volume":"75","author":"JP Kim","year":"2016","unstructured":"Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1414_CR11","unstructured":"The World Allergy Organization (WAO). The World Allergy Organization (WAO) White Book on Allergy 2013 Update. 2013; http:\/\/www.worldallergy.org\/UserFiles\/file\/WhiteBook2-2013-v8.pdf. Accessed June 1, 2018."},{"issue":"3","key":"1414_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaad.2015.10.043","volume":"74","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Eckert L, Wu R, Ardeleanu M, Graham NM, Pirozzi G, Mastey V. Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016;74(3):491\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2015.10.043.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"1414_CR13","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1080\/03007995.2016.1195733","volume":"32","author":"J Whiteley","year":"2016","unstructured":"Whiteley J, Emir B, Seitzman R, Makinson G. The Burden of atopic dermatitis in US adults: results from the 2013 National Health and Wellness Survey. Curr Med Res Opin. 2016;32(10):1645\u201351.","journal-title":"Curr Med Res Opin"},{"key":"1414_CR14","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/bjd.12590","volume":"169","author":"CR Charman","year":"2013","unstructured":"Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating patient-oriented eczema measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol. 2013;169:1326\u201332.","journal-title":"Br J Dermatol"},{"issue":"1S","key":"1414_CR15","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1097\/DER.0000000000000715","volume":"32","author":"W Smith Begolka","year":"2021","unstructured":"Smith Begolka W, Chovatiya R, Thibau IJ, Silverberg JI. Financial burden of atopic dermatitis out-of-pocket health care expenses in the United States. Dermatitis. 2021;32(1S):S62\u201370. https:\/\/doi.org\/10.1097\/DER.0000000000000715.","journal-title":"Dermatitis"},{"issue":"6S","key":"1414_CR16","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1097\/DER.0000000000000795","volume":"33","author":"R Chovatiya","year":"2022","unstructured":"Chovatiya R, Begolka WS, Thibau IJ, Silverberg JI. Impact and associations of atopic dermatitis out-of-pocket health care expenses in the United States. Dermatitis. 2022;33(6S):S43\u201351. https:\/\/doi.org\/10.1097\/DER.0000000000000795.","journal-title":"Dermatitis"},{"issue":"8 Suppl","key":"1414_CR17","first-page":"S115","volume":"23","author":"C Avena-Woods","year":"2017","unstructured":"Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23(8 Suppl):S115\u201323.","journal-title":"Am J Manag Care"},{"issue":"2","key":"1414_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","volume":"123","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(2):144\u201351.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"1414_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","volume":"143","author":"AS Paller","year":"2019","unstructured":"Paller AS, Spergel JM, Mina-Osorio P, Irvine AD. The atopic march and atopic multimorbidity: many trajectories, many pathways. J Allergy Clin Immunol. 2019;143(1):46\u201355.","journal-title":"J Allergy Clin Immunol"},{"issue":"10247","key":"1414_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. The Lancet. 2020;396(10247):345\u201360.","journal-title":"The Lancet"},{"issue":"1","key":"1414_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","volume":"137","author":"AM Drucker","year":"2017","unstructured":"Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Investig Dermatol. 2017;137(1):26\u201330.","journal-title":"J Investig Dermatol"},{"key":"1414_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19500","author":"K Eyerich","year":"2023","unstructured":"Eyerich K, Gooderham MJ, Silvestre JF, Shumack SP, Mendes-Bastos P, Aoki V, Ortoncelli M, Silverberg JI, Teixeira HD, Chen SH, Calimlim BM, Takemoto S, Sancho C, Fritz B, Irvine AD. Real-world clinical, psychosocial and economic burden of atopic dermatitis: results from a multicountry study. J Eur Acad Dermatol Venereol. 2023. https:\/\/doi.org\/10.1111\/jdv.19500.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"1414_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.20344\/amp.11963","volume":"32","author":"T Torres","year":"2019","unstructured":"Torres T, Ferreira EO, Gon\u00e7alo M, Mendes-Bastos P, Selores M, Filipe P. Update on atopic dermatitis. Acta Med Port. 2019;32(9):606\u201313. https:\/\/doi.org\/10.20344\/amp.11963.","journal-title":"Acta Med Port"},{"issue":"9","key":"1414_CR24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ad.2019.03.005","volume":"110","author":"D Carvalho","year":"2019","unstructured":"Carvalho D, Aguiar P, Ferrinho P, Mendes-Bastos P, Palma-Carlos A. Eczema and urticaria in the adult population in Portugal: a prevalence study. Actas Dermosifiliogr (Engl Ed). 2019;110(9):744\u201351. https:\/\/doi.org\/10.1016\/j.ad.2019.03.005.","journal-title":"Actas Dermosifiliogr (Engl Ed)."},{"issue":"5","key":"1414_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1684\/ejd.2022.4335","volume":"32","author":"G Stefanou","year":"2022","unstructured":"Stefanou G, Gregoriou S, Kontodimas S, Sfaelos K, Vakirlis E, Kourlaba G. Prevalence of adult self-reported atopic dermatitis in Greece: results from a nationwide survey. Eur J Dermatol. 2022;32(5):597\u2013606. https:\/\/doi.org\/10.1684\/ejd.2022.4335.","journal-title":"Eur J Dermatol"},{"issue":"1","key":"1414_CR26","doi-asserted-by":"publisher","first-page":"2415407","DOI":"10.1080\/09546634.2024.2415407","volume":"35","author":"B Darbellay","year":"2024","unstructured":"Darbellay B, Huber M, Bisschoff IJ, Guillod C, H\u00fcgel R, Pirkhammer D, Sator PG, Taskesen T, Lang CCV. Real-world burden of atopic dermatitis: Austrian and Swiss data from the MEASURE-AD study. J Dermatolog Treat. 2024;35(1):2415407. https:\/\/doi.org\/10.1080\/09546634.2024.2415407.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"1414_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000247298","volume":"186","author":"JF Stalder","year":"1993","unstructured":"Stalder JF, Ta\u00efeb A, Atherton DJ, Bieber P, Bonifazi E, Broberg A, et\u00a0al. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23\u201331.","journal-title":"Dermatology"},{"issue":"1","key":"1414_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1398-9995.2011.02719.x","volume":"67","author":"ME Schram","year":"2012","unstructured":"Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy. 2012;67(1):99\u2013106.","journal-title":"Allergy"},{"issue":"1","key":"1414_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","volume":"10","author":"JM Hanifin","year":"2001","unstructured":"Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis EASI Evaluator Group. Exp Dermatol. 2001;10(1):11\u20138.","journal-title":"Exp Dermatol"},{"key":"1414_CR30","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/bjd.13662","volume":"172","author":"YA Leshem","year":"2015","unstructured":"Leshem YA, Hajar T, Hanifin JM, Simpson EL. What the eczema area and severity index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol. 2015;172:1353\u20137.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1414_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jaci.2006.02.031","volume":"118","author":"T Zuberbier","year":"2006","unstructured":"Zuberbier T, Orlow SJ, Paller AS, Ta\u00efeb A, Allen R, Hernanz-Hermosa JM, Ocampo-Candiani J, Cox M, Langeraar J, Simon JC. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):226\u201332. https:\/\/doi.org\/10.1016\/j.jaci.2006.02.031.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1414_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2133.2009.09586.x","volume":"162","author":"S Elman","year":"2010","unstructured":"Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587\u201393. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09586.x.","journal-title":"Br J Dermatol"},{"key":"1414_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"1414_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/135581969700200105","volume":"2","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Layte R. Development and testing of the UK SF-12 (short-form health survey). J Health Serv Res Policy. 1997;2:14\u20138.","journal-title":"J Health Serv Res Policy"},{"key":"1414_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220\u201333.","journal-title":"Med Care"},{"key":"1414_CR36","first-page":"997","volume":"159","author":"MK Basra","year":"2008","unstructured":"Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The dermatology life quality index 1994\u20132007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159:997\u20131035.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1414_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000365390","volume":"230","author":"MK Basra","year":"2015","unstructured":"Basra MK, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the dermatology life quality index (DLQI): further data. Dermatology. 2015;230(1):27\u201333.","journal-title":"Dermatology"},{"issue":"5","key":"1414_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes E. The validity and reproducibility of a work productivity and activity impairment measure. Pharmacoeconomics. 1993;4(5):353\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"1414_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/all.13309","volume":"73","author":"PP Vakharia","year":"2018","unstructured":"Vakharia PP, Chopra R, Sacotte R, Patel N, Immaneni S, White T, Kantor R, Hsu DY, Silverberg JI. Validation of patient-reported global severity of atopic dermatitis in adults. Allergy. 2018;73(2):451\u20138. https:\/\/doi.org\/10.1111\/all.13309.","journal-title":"Allergy"},{"issue":"16","key":"1414_CR40","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/jcm11164777","volume":"11","author":"S Gregoriou","year":"2022","unstructured":"Gregoriou S, Stefanou G, Kontodimas S, Sfaelos K, Zavali M, Vakirlis E, Kourlaba G. Burden of atopic dermatitis in adults in Greece: results from a nationwide survey. J Clin Med. 2022;11(16):4777. https:\/\/doi.org\/10.3390\/jcm11164777.","journal-title":"J Clin Med"},{"issue":"1","key":"1414_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.alit.2021.10.002","volume":"71","author":"H Murota","year":"2022","unstructured":"Murota H, Koike Y, Morisaki H, Matsumoto M, Takenaka M. Exacerbating factors and disease burden in patients with atopic dermatitis. Allergol Int. 2022;71(1):25\u201330. https:\/\/doi.org\/10.1016\/j.alit.2021.10.002.","journal-title":"Allergol Int"},{"issue":"4","key":"1414_CR42","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.clindermatol.2017.03.008","volume":"35","author":"JI Silverberg","year":"2017","unstructured":"Silverberg JI. Selected comorbidities of atopic dermatitis: atopy, neuropsychiatric, and musculoskeletal disorders. Clin Dermatol. 2017;35(4):360\u20136. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.03.008.","journal-title":"Clin Dermatol"},{"issue":"6S","key":"1414_CR43","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1097\/DER.0000000000000799","volume":"33","author":"R Chovatiya","year":"2022","unstructured":"Chovatiya R, Silverberg JI. Iatrogenic burden of atopic dermatitis. Dermatitis. 2022;33(6S):S17\u201323. https:\/\/doi.org\/10.1097\/DER.0000000000000799.","journal-title":"Dermatitis"},{"issue":"3","key":"1414_CR44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2340\/00015555-3102","volume":"99","author":"AGS Zink","year":"2019","unstructured":"Zink AGS, Arents B, Fink-Wagner A, Seitz IA, Mensing U, Wettemann N, de Carlo G, Ring J. Out-of-pocket costs for individuals with atopic eczema: a cross-sectional study in nine European countries. Acta Derm Venereol. 2019;99(3):263\u20137. https:\/\/doi.org\/10.2340\/00015555-3102.","journal-title":"Acta Derm Venereol"},{"key":"1414_CR45","unstructured":"DUPIXENT Summary of Product Characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/dupixent-epar-product-information_en.pdf. Accessed on 19 Mar 2025."},{"issue":"10","key":"1414_CR46","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s13555-023-01000-3","volume":"13","author":"JI Silverberg","year":"2023","unstructured":"Silverberg JI, Hong HC, Calimlim BM, Lee WJ, Teixeira HD, Collins EB, Crowell MM, Johnson SJ, Armstrong AW. Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis. Dermatol Ther (Heidelb). 2023;13(10):2247\u201364. https:\/\/doi.org\/10.1007\/s13555-023-01000-3.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"5","key":"1414_CR47","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s13555-023-00920-4","volume":"13","author":"SM Ferrucci","year":"2023","unstructured":"Ferrucci SM, Tavecchio S, Marzano AV, Buffon S. Emerging systemic treatments for atopic dermatitis. Dermatol Ther. 2023;13(5):1071\u201381. https:\/\/doi.org\/10.1007\/s13555-023-00920-4.","journal-title":"Dermatol Ther"},{"issue":"1","key":"1414_CR48","doi-asserted-by":"publisher","first-page":"2297450","DOI":"10.1080\/19420862.2023.2297450","volume":"16","author":"S Crescioli","year":"2024","unstructured":"Crescioli S, Kaplon H, Chenoweth A, Wang L, Visweswaraiah J, Reichert JM. Antibodies to watch in 2024. MAbs. 2024;16(1):2297450. https:\/\/doi.org\/10.1080\/19420862.2023.2297450.","journal-title":"MAbs"},{"issue":"5","key":"1414_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.anai.2023.01.020","volume":"130","author":"D Mikhaylov","year":"2023","unstructured":"Mikhaylov D, Ungar B, Renert-Yuval Y, Guttman-Yassky E. Oral Janus kinase inhibitors for atopic dermatitis. Ann Allergy Asthma Immunol. 2023;130(5):577\u201392. https:\/\/doi.org\/10.1016\/j.anai.2023.01.020.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1414_CR50","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2340\/actadv.v102.2075","volume":"102","author":"FB Sedeh","year":"2022","unstructured":"Sedeh FB, Henning MAS, Jemec GBE, Ibler KS. Comparative efficacy and safety of monoclonal antibodies and Janus kinase inhibitors in moderate-to-severe atopic dermatitis: a systematic review and meta-analysis. Acta Derm Venereol. 2022;102:764. https:\/\/doi.org\/10.2340\/actadv.v102.2075.","journal-title":"Acta Derm Venereol"},{"key":"1414_CR51","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2022.29004.sna","author":"S Narla","year":"2023","unstructured":"Narla S, Silverberg JI. Safety of oral Janus kinase inhibitors in the treatment of moderate-to-severe atopic dermatitis. Dermatitis. 2023. https:\/\/doi.org\/10.1089\/derm.2022.29004.sna.","journal-title":"Dermatitis"},{"issue":"3","key":"1414_CR52","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s13555-023-00892-5","volume":"13","author":"C Samuel","year":"2023","unstructured":"Samuel C, Cornman H, Kambala A, Kwatra SG. A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring. Dermatol Ther. 2023;13(3):729\u201349. https:\/\/doi.org\/10.1007\/s13555-023-00892-5.","journal-title":"Dermatol Ther"},{"key":"1414_CR53","unstructured":"Pedro Mendes-Bastos, E Lazaridou et\u00a0al (2022). Multidimensional burden of moderate-to-severe atopic dermatitis in adolescent and adult patients from Portugal and Greece: results from the cross-sectional study MEASURE-AD., 21 Congresso Nacional Dermatologia Venereologia."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01414-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01414-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01414-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T12:48:42Z","timestamp":1747745322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01414-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1414"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01414-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pedro Mendes-Bastos has received honoraria for acting as consultant\/speaker\/principal Investigator for AbbVie, Almirall, Amgen, Apogee, Biogen, CS Labs, Eli-Lilly, Evelo Biosciences, Janssen-Cilag, Leo-Pharma, L\u2019Oreal, Novartis, Organon, Pfizer, Pierre Fabre, Regeneron, Sanofi, and Viatris. Elisavet Lazaridou has received honoraria for acting as a consultant and\/or as a speaker for Abbvie, UCB, Novartis, Janssen, Pfizer, LEO Pharma, Amgen, Sanofi, Pharmaserve Lilly, Pierre Fabre, L\u2019oreal, and Genesis Pharma. Elisavet Lazaridou served as an investigator in clinical trials supported by Abbvie, UCB, Janssen, Leo, Amgen, L\u2019oreal, and Boehringer Ingelheim. Tiago Torres has received honoraria for acting as a consultant and\/or as a speaker for Abbvie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers-Squibb, Celgene, Janssen, LEO Pharma, Eli-Lilly, MSD, Mylan, Novartis, Pfizer, Sanofi Genzyme, Sandoz, Samsung-Bioepis, UCB, and Viatris. Tiago Torres is or has been a principal investigator in clinical trials supported by AbbVie, Amgen, Janssen, Novartis, and Sanofi. Tiago Torres is an Editorial Board member of Dermatology and Therapy. Tiago Torres was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Charalampos Aggelakopoulos has no conflicts of interest. Ioannis Katsantonis is or has been a principal investigator in clinical trials supported by AbbVie, UCB, Novartis, LEO Pharma, and Amgen. Pantelis Aronis has no conflicts of interest. Dimitrios Rigopoulos has received honoraria for acting as a consultant and\/or as a speaker for AbbVie, Genesis Pharma, Amgen, UCB, Novartis, and LEO Pharma. Dimitrios Rigopoulos served as an investigator in clinical trials supported by AbbVie, Genesis Pharma, Amgen, UCB, and Novartis. Current affiliation of Dimitrios Rigopoulos is Hygeia Hospital, Kifisias Av. 151 23, Marousi, Athens, Greece. Filomena Azevedo has no conflicts of interest. Felicidade Santiago has no conflicts of interest. Current affiliation of Felicidade Santiago is Unidade Local de Sa\u00fade de Coimbra, Praceta Professor Mota Pinto, 3004\u2013561 Coimbra, Portugal. Markos Papakonstantis served as an investigator and\/or consultant or speaker for AbbVie, Faran, Janssen, LEO Pharma, Pharmaserve Lilly, Novartis, Pfizer, and UCB. Paulo Varela served as an investigator and\/or consultant or speaker for Abbvie, Almirall, Boehringer, Janssen, Leo, Lilly, Pfizer, Sandoz, and Sanofi. Vera S. G. Ribeiro and Aikaterini Kollia are employees of AbbVie Pharmaceuticals. Evaggelia Papadavid has received honoraria for acting as a consultant and\/or as a speaker for AbbVie, Janssen, UCB, Novartis, Pharmaserve Lilly, Amgen, Takeda, Recordati, and Pfizer. Evaggelia Papadavid served as an investigator in clinical trials supported by Helsinn, Recordati, Novartis, and Janssen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study received approval from the institutional review boards of all involved institutions. The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All subjects (or that person\u2019s parent or legal guardian) provided informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}